The Administration of Cannabinoid Receptor 2 Agonist Decreases Binge-like Intake of Palatable Food in Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26051981 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Luis Miguel Rodríguez-Serrano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Psicología, Universidad Anáhuac México, Universidad Anáhuac Avenue #46, Lomas Anáhuac, Huixquilucan 52786, Mexico. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB2, Binge-Eating Disorder, Cannabinoid Receptor Agonists, Feeding Behavior. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Facultad de Psicología, Universidad Anáhuac México Campus Norte, Dirección de Investigación, Universidad Anáhuac México.
Abstract (Originalsprache)
Binge eating disorder (BED) is characterized by uncontrollable episodes of eating in a short period of time, with a subjective loss of control of overconsumption behavior. The role CB2 cannabinoid receptor (CB2R) plays in binge-like intake has not yet been identified. In this regard, the present study aims to evaluate the effect of the administration of CB2R agonist, antagonist, or both on binge-like intake of palatable food (PF) in adolescent mice. We used 35 C57BL6/J male mice of 30 postnatal days in this research; all animals were housed individually and had ad libitum access to a standard diet (SD) and water. Animals were evaluated for a total of 15 sessions of the Binge Eating Test (BET), which consisted of 1 h access to PF (chocolate sandwich cookies) according to intermittent diet protocol, with one-day access/one-day no-access. PF and SD caloric intake, as well as the PF binge index (defined as consuming ≥20% of total caloric intake per day during the 1 h access to PF), were analyzed. Mice were randomly assigned to one of the following treatment groups: (1) control; (2) vehicle; (3) HU308, selective CB2R agonist; (4) AM630, selective CB2R antagonist; (5) AM630+HU308 coadministration of antagonist and agonists of CB2R. All treatments were administered intraperitoneally before BET sessions. Our results show that HU308 significantly reduced binge-like intake of PF, while no significant differences were found in the rest of the groups. These results suggest that activation of the CB2R decreases the binge-like intake in adolescent mice and that chronic overconsumption in conditions of non-homeostatic feeding can be modulated by the CB2R. Furthermore, the activation of CB2R may also modulate reward pathways, reducing binge-like behavior, which could be further explored in future studies as a treatment for BED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Psicología, Universidad Anáhuac México, Universidad Anáhuac Avenue #46, Lomas Anáhuac, Huixquilucan 52786, Mexico.
ORCID-Profile: Luis Miguel Rodríguez-Serrano
Förderung
- Facultad de Psicología, Universidad Anáhuac México Campus Norte
- Dirección de Investigación, Universidad Anáhuac México
Zitieren
APA
Rodríguez-Serrano, L. M., & Chávez-Hernández, M. E. (2025). The Administration of Cannabinoid Receptor 2 Agonist Decreases Binge-like Intake of Palatable Food in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26051981
Vancouver
Rodríguez-Serrano LM, Chávez-Hernández ME. The Administration of Cannabinoid Receptor 2 Agonist Decreases Binge-like Intake of Palatable Food in Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26051981
BibTeX
@article{RodrguezSerrano2025,
author = {Rodríguez-Serrano, Luis Miguel and Chávez-Hernández, María Elena},
title = {The Administration of Cannabinoid Receptor 2 Agonist Decreases Binge-like Intake of Palatable Food in Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26051981}
}
EUVIMED